Study of Talabostat and Cisplatin in Advanced Melanoma

NCT00083252 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Melanoma
Skin Cancer

Interventions

DRUG: talabostat (PT-100) tablets
DRUG: cisplatin

Sponsor

Point Therapeutics